Company Filing History:
2 out of 3,539 
1 out of 276 
1 out of 647 
Years Active: 2014
Title: Frederic Bibollet-Ruche: Innovator in HIV Research
Introduction
Frederic Bibollet-Ruche is a distinguished inventor based in Birmingham, Alabama, recognized for his pivotal contributions to the field of biomedical research, particularly in the fight against human immunodeficiency virus type 1 (HIV-1). With two patents to his name, Bibollet-Ruche's work encompasses innovative methodologies aimed at enhancing immunogenicity and neutralization against HIV.
Latest Patents
Bibollet-Ruche's latest patents focus on the development of molecular scaffolds for HIV-1 immunogens. The first patent presents methods and compositions involving chimeric polypeptides that incorporate various heterologous epitopes recognized by HIV-1 neutralizing antibodies. These molecular scaffolds effectively enhance the presentation of these epitopes, thereby improving immune response. Additionally, he innovatively employs polynucleotides encoding these chimeric polypeptides, leading to the creation of advanced immunogenic compositions and potential vaccines for HIV-1 prevention.
The second patent introduces the use of envelope polypeptides from lentiviruses other than HIV-1 as scaffolds for HIV-1 epitopes. This groundbreaking approach allows for the detection of HIV-1 binding antibodies in infected subjects and includes methods for neutralizing non-HIV-1 viruses, diagnostic assays, and immunization monitoring.
Career Highlights
Throughout his career, Bibollet-Ruche has collaborated with key organizations, including the United States of America as represented by the Secretary of the Department of Health and Human Services and the UAB Research Foundation at the University of Alabama—Birmingham. His work plays a vital role in the ongoing fight against HIV through innovative research and practical applications.
Collaborations
Frederic Bibollet-Ruche has worked alongside noted researchers, such as George M. Shaw and Beatrice H. Hahn, contributing to a collaborative environment that fosters scientific advancements. Together, they aim to unravel the complexities of HIV and enhance therapeutic interventions.
Conclusion
Frederic Bibollet-Ruche stands as a prominent figure in the realm of HIV research, with his innovative patents demonstrating significant potential for advancing the development of effective immunogens and vaccines. His relentless pursuit of innovation not only contributes to scientific knowledge but also offers hope for future breakthroughs in combating HIV-1.